Ignite Creation Date:
2025-12-24 @ 11:18 PM
Ignite Modification Date:
2025-12-25 @ 8:58 PM
Study NCT ID:
NCT01226056
Status:
SUSPENDED
Last Update Posted:
2010-10-21
First Post:
2010-10-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Sorafenib in Combination With RAD001 in Advanced Solid Tumors Selected on Molecular Targets
Sponsor:
Southern Europe New Drug Organization
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-03
Start Date Type:
None
Primary Completion Date:
2012-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2012-12
Completion Date Type:
ESTIMATED
First Submit Date:
2010-10-18
First Submit QC Date:
None
Study First Post Date:
2010-10-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-10-20
Last Update Post Date:
2010-10-21
Last Update Post Date Type:
ESTIMATED